PubRank

B K Shenton

Author PubWeight™ 85.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg 2006 3.91
2 Specific laboratory test for diagnosis of multiple sclerosis. Br Med J 1974 2.17
3 Tumour cell dissemination following endoscopic stent insertion. Br J Surg 2007 2.10
4 The influence of surgical operations on components of the human immune system. Br J Surg 1985 1.75
5 Unsaturated fatty acids in multiple sclerosis. Br Med J 1973 1.75
6 Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival. Br J Surg 1991 1.50
7 Experiences learned in the successful establishment of a nonheart beating donor program for renal transplantation. J Urol 2003 1.45
8 Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection. Transpl Int 1993 1.41
9 The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study. Br J Cancer 1998 1.40
10 Effect of perioperative blood transfusion on recurrence of colorectal cancer. Br J Surg 1986 1.36
11 Blood transfusion and tumour growth: evidence from laboratory animals. Lancet 1981 1.27
12 Human endothelial cells: effect of TNF-alpha on peripheral blood mononuclear cell adhesion. Immunology 1991 1.19
13 Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection. Br J Cancer Suppl 1973 1.15
14 In-vitro inhibition by unsaturated fatty acids of the PPD- and PHA-induced lymphocyte response. Klin Wochenschr 1974 1.13
15 Inhibitory effect of unsaturated fatty acids on lymphocyte-antigen interaction with special reference to multiple sclerosis. Acta Neurol Scand 1975 1.09
16 Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc 2005 1.04
17 Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. Br J Cancer 1996 1.03
18 Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma. Ann R Coll Surg Engl 1990 1.01
19 Flow cytometric method for the measurement of epidermal growth factor receptor and comparison with the radio-ligand binding assay. Cytometry 1994 1.00
20 The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population. J Cell Physiol 2007 0.97
21 Cytokeratin expression in breast cancer: phenotypic changes associated with disease progression. Cytometry 1998 0.94
22 Lymphocyte sensitization after exposure to measles, and influenza. Possible relevance to pathogenesis of multiple sclerosis. J Neurol Sci 1973 0.93
23 Effect of gamma-linolenate in multiple sclerosis. Lancet 1976 0.92
24 Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg 2012 0.92
25 Use of the biotinylated antibody DAKO-ER 1D5 to measure oestrogen receptor on cytokeratin positive cells obtained from primary breast cancer cells. Cytometry 1995 0.91
26 Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study. Br J Cancer 1999 0.90
27 Are fine-needle breast aspirates representative of the underlying solid tumour? A comparison of receptor levels, ploidy and the influence of cytokeratin gates. Br J Cancer 1995 0.90
28 Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood. J Immunol Methods 2002 0.90
29 Letter: Effect of polyunsaturated fatty acids on lymphocyte activity. Br Med J 1973 0.90
30 Anomalous lymphocyte-antigen reaction in relatives of multiple sclerosis patients. A study of a possible genetic factor in the disease. J Neurol 1977 0.90
31 A comparison of the kinetics of the macrophage electrophoretic mobility (MEM) and the tanned sheep erythrocyte electrophoretic mobility (TEEM) tests. J Immunol Methods 1977 0.86
32 A new mechanism of humoral immunodepression in chronic renal failure and its importance to dialysis and transplantation. Proc Eur Dial Transplant Assoc 1983 0.86
33 Renal allograft rejection: induction and function of adhesion molecules on cultured epithelial cells. Clin Exp Immunol 1992 0.86
34 Letter: Diagnostic test for multiple sclerosis. Br Med J 1974 0.85
35 Use of the monoclonal antibody DAKO-ERbeta (8D5-1) to measure oestrogen receptor beta in breast cancer cells. Cytometry 2001 0.85
36 Renal allograft rejection: expression and function of VCAM-1 on tubular epithelial cells. Clin Exp Immunol 1993 0.85
37 MUC1 expression in primary breast cancer: the effect of tamoxifen treatment. Breast Cancer Res Treat 2001 0.85
38 Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2001 0.85
39 Identification of immunosuppressive factors in plasma following multiple blood transfusions. Transplant Proc 1979 0.84
40 Use of thrombolytic streptokinase as a preflush in the NHBD procurement. Transplant Proc 2003 0.83
41 Ischemia-reperfusion injury in cadaveric nonheart beating, cadaveric heart beating and live donor renal transplants. J Urol 2006 0.83
42 Renal allograft rejection: the temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1. Transpl Int 1995 0.83
43 Lymphocyte sensitisation in myasthenia gravis: function of the adult thymus gland. Lancet 1973 0.83
44 Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler. Transpl Infect Dis 2004 0.83
45 Natural killer cells in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1986 0.82
46 The proliferative effects of 5-androstene-3 beta,17 beta-diol and 5 alpha-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines. J Steroid Biochem Mol Biol 2004 0.82
47 The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients. Transplantation 1995 0.82
48 A rapid, objective method for the detection of lymphocytotoxic antibodies using flow cytometry. J Immunol Methods 1987 0.81
49 Plasma suppressive activity and kidney graft survival. Br J Surg 1980 0.81
50 The clinical significance of post-transplantation non-HLA antibodies in renal transplantation. Transpl Int 1995 0.80
51 Standardization of lymphocyte antibody binding capacity - a multi-centre study. Clin Lab Haematol 2000 0.80
52 Renal allograft rejection. Possible involvement of antibody-dependent cell-mediated cytotoxicity. Transplantation 1990 0.80
53 In situ subpopulations of lymphocytes in human colorectal carcinomas. Invasion Metastasis 1984 0.79
54 A flow cytometric study of c-erbB-3 expression in breast cancer. Cancer Immunol Immunother 1995 0.79
55 Passive transfer of lymphocytes from diabetic man to athymic mouse. Lancet 1979 0.79
56 p53 expression measured by flow cytometry. A comparison of three monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer. Cancer Immunol Immunother 1995 0.79
57 Immunosuppression by human alpha 2-macroglobulin, a 3800 Mr peptide, and other derivatives. Ann N Y Acad Sci 1983 0.79
58 Growth dysregulation and p53 accumulation in human primary colorectal cancer. Br J Cancer 1999 0.79
59 Abnormalities in p53 and DNA content in transitional cell carcinoma of the bladder. Br J Urol 1994 0.79
60 A flow cytometric technique for simultaneous analysis of human mononuclear cell surface antigens and DNA. J Immunol Methods 1989 0.78
61 Immunosuppressive plasma factors in malignant disease. Aust N Z J Surg 1985 0.78
62 TEEM-test studies on effect of aprotinin on in vitro response of cancer patients' lymphocytes to PPD. Br J Cancer 1978 0.78
63 Renal allograft rejection. Functional impairment of kidney epithelial cell monolayers mediated by lymphokine-activated killer cells and by antibody. Transplantation 1991 0.77
64 Value of the flow cytometric crossmatch in renal transplantation. Transplant Proc 1987 0.77
65 Cellular sensitization in kuru, Jakob-Creutzfeldt disease and multiple sclerosis: with a note on the biohazards of slow infection work. Acta Neurol Scand 1975 0.77
66 Alterations in circulating lymphocyte number and function after circulation through colorectal carcinomas. Surgery 1991 0.77
67 The macrophage electrophoretic mobility test (MEM) some technical considerations. J Immunol Methods 1975 0.77
68 A correction required for calculation of DNA ratios in flow cytometric analysis of ploidy. Cytometry 1988 0.77
69 Renal allograft rejection: examination of adhesion blockade by antilymphocyte antibody drugs. Nephrol Dial Transplant 1993 0.77
70 Long-term renal function after transplantation from non-heart-beating donor kidneys. Transplant Proc 2002 0.76
71 Fat emulsion adversely affects lymphocyte reactivity. Aust N Z J Surg 1987 0.76
72 Anti-vimentin antibody detection in recipients of heart-beating and non-heart beating donor kidneys. Transplant Proc 2005 0.76
73 Neutrophil transmigration: modulation by pentoxifylline and nitric oxide. Biochem Soc Trans 1997 0.76
74 Cardiovascular risk assessment scoring system for the determination of cardiovascular mortality in renal transplant patients. Transplant Proc 2005 0.76
75 Weight increase during machine perfusion may be an indicator of organ and in particular, vascular damage. Ann Transplant 2004 0.76
76 Immunoelectrophoretic pattern of alpha 2-macroglobulin and alpha 2-macroglobulin-protease complexes. Clin Chim Acta 1990 0.76
77 Re-evaluation of viability testing of cadaveric kidneys for transplantation. Br J Urol 1981 0.76
78 Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometry. Eur J Cancer 1996 0.76
79 Altered response to scrapie tissues in neurological disease. Possible evidence for an antigen associated with reactive astrocytes. Brain 1973 0.76
80 Emergence of new antigens in ageing tissues. Gerontologia 1973 0.76
81 Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls. Clin Chem 1999 0.76
82 P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder. Br J Urol 1994 0.75
83 Immunological reactions in scrapie: the basis of a rapid titration method. Pathol Biol (Paris) 1973 0.75
84 Plasma interleukin 2 receptor levels in renal allograft dysfunction. Transplantation 1989 0.75
85 The value of plasma-soluble interleukin 2 receptor monitoring in lung transplantation. Transplantation 1993 0.75
86 Pump upgrade for machine perfusion at the Freeman Hospital in Newcastle. Transpl Int 2001 0.75
87 Letter: Linoleic acid in multiple sclerosis. Br Med J 1975 0.75
88 Letter: Diagnostic test for multiple sclerosis. Br Med J 1975 0.75
89 Rapid diagnosis of scrapie in the mouse. Nature 1972 0.75
90 The relevance of a more sensitive crossmatch assay to renal transplantation. Transplantation 1989 0.75
91 Rapid detection of low levels of donor specific IgG by flow cytometry with single and dual colour fluorescence in renal transplantation. J Immunol Methods 1988 0.75
92 A rapid immunologic test for scrapie in sheep. Am J Vet Res 1974 0.75
93 Multiple sclerosis and measles: a study of cellular sensitization. Eur Neurol 1976 0.75
94 Alpha 2-macroglobulin and generation of oxygen radicals by granulocytes: potential role in prevention and treatment of reperfusion injury. Clin Chim Acta 1991 0.75
95 The blood transfusion effect and colorectal cancer recurrence. Transplant Proc 1987 0.75
96 Are DRW6-positive patients high responders? Transplant Proc 1984 0.75
97 Flow cytometric crossmatching and outcome one year after renal transplantation. Transpl Int 1992 0.75
98 Effect of anti CD45 on different immunosuppressive regimes in renal transplantation. Transplant Proc 1996 0.75
99 A possible mechanism of immunoregulation produced by alpha 2-macroglobulin. Ann N Y Acad Sci 1983 0.75
100 The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer. Cancer Immunol Immunother 1995 0.75
101 Blood transfusion and renal transplantation. Br J Surg 1979 0.75
102 Creatinine clearance and viability biomarkers of machine perfused non-heart-beating donors: is there a correlation? Transplant Proc 2003 0.75
103 Inhibition of natural killing and antibody-dependent cell-mediated cytotoxicity by the plasma protease inhibitor alpha 2-macroglobulin (alpha 2M) and alpha 2M protease complexes. Clin Immunol Immunopathol 1985 0.75
104 Electrophoretic mobility test for lymphocyte sensitization using tanned sheep erythrocytes. Acta Biol Med Ger 1975 0.75
105 Do recipients of kidneys from donors treated with streptokinase develop anti-streptokinase antibodies? Transplant Proc 2005 0.75
106 Rapid immunological method for diagnosis of natural scrapie in sheep. Nature 1973 0.75
107 Experimental renal transplantation: IgG antibodies which bind to graft tubular epithelial cells cannot be detected in the serum of recipient rats after pre-operative transfusion of donor blood. Int Arch Allergy Immunol 1993 0.75
108 Possible mechanism of immune regulation produced by alpha2M-macroglobulin. Lancet 1982 0.75
109 A phase I study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738). Eur J Cancer Clin Oncol 1989 0.75
110 CAPD and renal transplantation. Br J Surg 1985 0.75
111 Blood-transfusion and renal transplantation. Lancet 1978 0.75
112 Flow cytometric crossmatching in renal transplantation--the long-term outcome. Transpl Immunol 1995 0.75
113 Is voided urine suitable for flow cytometric DNA analysis? Br J Urol 1991 0.75
114 Thymectomy and immunological ageing in mice: precocious emergence of scrapie-like antigen. Gerontologia 1973 0.75
115 The flow cytometric crossmatch in liver transplantation. Transplantation 1995 0.75
116 P53 and ploidy assessed by flow cytometry in bladder washings. Br J Urol 1995 0.75
117 The clinical relevance of alpha 2-macroglobulin. Ann N Y Acad Sci 1983 0.75
118 Changes in EBV gene load in renal transplant recipients. Transplant Proc 2003 0.75
119 The role of protease in immunoregulation. Br J Surg 1983 0.75
120 Improved graft outcome and reduced complications due to flow cytometric crossmatching and DR matching in renal transplantation. Transplantation 1992 0.75
121 Production of immunosuppressive factors by a cultured tumour cell line and their effect on lymphocyte proliferation and cell cycle response. Surg Oncol 1993 0.75
122 Serum adrenal androgens in women with primary operable breast cancer and their relationship with age and body mass index. Breast 2003 0.75
123 Aspirate cellularity as a rapid indicator of renal allograft rejection. Br J Surg 1986 0.75
124 Mechanisms in chronic inflammation. Immunol Today 1984 0.75
125 Transfusion-induced immunosuppression and red cell clearance. Transfus Med 1991 0.75
126 Letter: Linoleic acid and transplantation. Lancet 1975 0.75
127 Use of streptokinase in a non-heart-beating donor animal model. Transplant Proc 2002 0.75
128 Control values of lymphocyte subsets in healthy volunteers. Transplantation 1985 0.75
129 The effect of improvements in cytometer sensitivity on the detection of CD5-positive B cells with dim fluorescence. Cytometry 1991 0.75
130 Reperfusion injury in renal transplantation: comparison of LD, HBD and NHBD renal transplants. Ann Transplant 2004 0.75
131 Thallous chloride uptake and DNA profile in parathyroid adenomas. Br J Surg 1990 0.75
132 Letter: Assay of thymosin in blood. Lancet 1975 0.75
133 The prospective value of the preoperative flow cytometric crossmatch assay in renal transplantation. Transplantation 1990 0.75
134 Renal epithelium: reversal of cytotoxic damage by addition of anti-thymocyte globulin. Transpl Int 1991 0.75
135 Scrapie-like antigen(s) in ageing tissues. Nature 1973 0.75
136 Transfusion effect in renal transplants. Lancet 1982 0.75
137 The assessment of histocompatibility by mixed lymphocyte reaction as measured by the macrophage electrophoretic mobility (MEM) test. Tissue Antigens 1975 0.75
138 Flow-cytometric monitoring of ATG therapy for steroid-resistant rejection. Transplant Proc 1992 0.75
139 Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer. Oncology 1999 0.75
140 Characterization of donor-directed antibody class in the post-transplant period using flow cytometry in renal transplantation. Transpl Int 1994 0.75
141 Flow cytometric crossmatching in renal transplantation--outcome after five years. Transpl Int 1996 0.75
142 Evaluation of the flow cytometric crossmatch. Preliminary results of a multicenter study. Transplantation 1996 0.75
143 Creatinine clearance in recipients of kidneys from non-heart-beating donors. Transplant Proc 2001 0.75
144 Letter: Inhibition of lymphocyte response to stimulants by unsaturated fatty acids and prostaglandins. Lancet 1974 0.75
145 Mixed lymphocyte reaction in multiple sclerosis. Acta Neurol Scand 1976 0.75
146 Letter: Aetiopathogenesis of multiple sclerosis. Lancet 1974 0.75
147 Monitoring of transplant patients' lymphocytes: knowledge of the varying specificities of anti-lymphocyte antibodies allows the interpretation of anomalous results. Clin Immunol Immunopathol 1990 0.75
148 Letter: Unsaturated fatty acids and renal transplantation. Lancet 1974 0.75
149 Value of flow cytometric monitoring of posttransplant antibody status in renal transplantation. Transplant Proc 1993 0.75
150 DR typing in less than three hours using a flow cytometer. Transplant Proc 1988 0.75